PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
http://www.peervoice.com
Eine durchschnittliche Folge dieses Podcasts dauert 19m.
Bisher sind 245 Folge(n) erschienen.
Dies ist ein wöchentlich erscheinender Podcast.
Gesamtlänge aller Episoden: 3 days 21 hours 37 minutes
Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?
Treatment Update in Type 2 Diabetes: What’s New, and What Does It Mean for Patients?
A Heart to Heart in Cardio-Oncology: Optimizing Cardiovascular Health With BTK Inhibitors for CLL
A Heart to Heart in Cardio-Oncology: Optimizing Cardiovascular Health With BTK Inhibitors for CLL
Practicalities in the Management of Hypertrophic Cardiomyopathy: A Case-Based Approach
Practicalities in the Management of Hypertrophic Cardiomyopathy: A Case-Based Approach
PARPs in Practice in mCRPC: A Look at the Latest Data
PARPs in Practice in mCRPC: A Look at the Latest Data
Managing Risk of Persistent Acute Kidney Injury in the ICU: The RUBY Study
Managing Risk of Persistent Acute Kidney Injury in the ICU: The RUBY Study